Did You Know?

Editor’s Picks

Latest News

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis – Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

PARAMUS, NJ, May 28, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (the “Company” or “Polaryx”) (Nasdaq: PLYX), a clinical-stage biotechnology...

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patientsCollaboration supports the...

error: Content is protected !!